SCHEMBL7213164

SCHEMBL7213164

CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Br)cc2C(=O)Nc2ccc(Br)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC10A6 Q3KNW5 2/20 0.71
SLC10A2 Q12908 1/20 0.71
SLC10A1 Q14973 1/20 0.71
METAP2 P50579 2/20 0.54
GPR27 Q9NS67 5/20 0.54
KDM1A O60341 1/20 0.54
HDAC3 O15379 2/20 0.53
HDAC11 Q96DB2 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
HDAC6 Q9UBN7 2/20 0.53
AVPR2 P30518 2/20 0.53
PTPN5 P54829 1/20 0.49
HSD17B2 P37059 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
CYP1A2 P05177 1/20 0.48
POLB P06746 1/20 0.48
CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7116008 0.91 SLC10A6 (0.85) SLC10A6SLC10A2SLC10A1METAP2GPR27
SCHEMBL7627121 0.89 SLC10A6 (0.71) SLC10A6SLC10A2SLC10A1METAP2GPR27
SCHEMBL18341250 0.85 SLC10A6 (0.66) SLC10A6SLC10A2SLC10A1METAP2GPR27
SCHEMBL7126120 0.85 SLC10A6 (0.98) SLC10A6SLC10A2SLC10A1METAP2GPR27
SCHEMBL7208184 0.85 SLC10A6 (0.76) SLC10A6SLC10A2SLC10A1METAP2GPR27
SCHEMBL7120319 0.84 SLC10A6 (0.76) SLC10A6SLC10A2SLC10A1METAP2GPR27
SCHEMBL4649665 0.84 METAP2 (0.74) SLC10A6SLC10A2SLC10A1METAP2KDM1A
SCHEMBL5118300 0.84 SLC10A6 (0.68) SLC10A6SLC10A2SLC10A1GPR27HSD17B2
SCHEMBL7128123 0.84 SLC10A6 (0.71) SLC10A6SLC10A2SLC10A1METAP2GPR27
SCHEMBL6756862 0.83 SLC10A6 (1.00) SLC10A6SLC10A2SLC10A1METAP2GPR27

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US claimed
CN-1358062-A Macrophage scavenger receptor antagonists SMITHKLINE BEECHAM CORP (US) 2002-07-10 CN claimed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP claimed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO claimed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US disclosed
CN-1358062-A Macrophage scavenger receptor antagonists SMITHKLINE BEECHAM CORP (US) 2002-07-10 CN disclosed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO disclosed